MARKET OPEN: Covid drug trial sets upbeat tone for local trading

MARKET OPEN: Covid drug trial sets upbeat tone for local trading
Paul McBeth
New Zealand’s stock market may be in for a positive start to the week after Wall Street closed stronger on Friday on optimism over a late-stage trial of the Remdesivir drug in treating covid-19. Investor optimism over the economic recovery from the covid-19 pandemic was stoked by drug company Gilead’s news that its antiviral remdesivir product significantly aided the recovery of severely ill patients. Australia’s Therapeutics Goods Administration gave provisional approval for remdesivir to be used in adults with severe covid symptoms. “Gi...

More Markets

Nvidia earnings boost markets, NZ sharemarket closes up
Markets Market Close

Nvidia earnings boost markets, NZ sharemarket closes up

The S&P/NZX 50 Index closed up 0.84% or 112.502 points. 

Tom Raynel 20 Nov 2025
Jade Software to acquire Contec Group
Markets

Jade Software to acquire Contec Group

The acquisition adds Contec’s Madcap software to Jade’s portfolio.

John Anthony 20 Nov 2025
AFT forges ahead with China iron injectable deal
Markets

AFT forges ahead with China iron injectable deal

Oldest iron products in Aussie are booming, while new iron injectable gets China boost.

Meridian says hydro is key to energy security and affordability
Markets

Meridian says hydro is key to energy security and affordability

Meridian says it has learnt lessons from winter 2024.

Ian Llewellyn 20 Nov 2025